New Zealand is one of a handful of countries that aimed to eliminate COVID-19. We generated SARS-CoV-2 genomes from infected patients collected during outbreaks of the disease in New Zealand.
Using these data we report on the genomic diversity, transmission dynamics and spread of SARS-CoV-2. These data helped to quantify the effectiveness of public health interventions and inform the source of new outbreaks in the community. Overall, our findings demonstrate the utility of genomic pathogen surveillance to inform public health and disease mitigation.
|Date||Monday, 12 April 2021|
|Time||12:00pm - 1:00pm|
|Event Category||Health Sciences|
|Department||Microbiology and Immunology|
|Location||Microbiology Bldg,, 720 Cumberland Street, 2nd Floor – Room 208, Dunedin|
|Contact Name||Jennifer van Eunen|
|Contact Phone||+64 3 479 7734|